Form 4: MACOM CEO Stephen Daly Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


MACOM Technology Solutions CEO Stephen Daly sold a total of 45,090 shares of common stock on November 13, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • Stephen Daly, the President and CEO of MACOM Technology Solutions Holdings, Inc., sold 45,090 shares of common stock on November 13, 2024.
  • The sales were executed under a pre-arranged trading plan adopted on May 31, 2024, designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • The shares were sold in multiple transactions at weighted average prices of $128.65, $129.62, and $130.43.
  • The sales resulted in a reduction of Daly's direct holdings of MACOM common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine insider stock sale under a pre-arranged plan, which is neither particularly positive nor negative.

Risks

  • Sales by company insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.

Industry Context

Insider sales are a common occurrence, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on non-public information. This transaction is not unusual for executives of publicly traded companies.

Comparison to Industry Standards

  • The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the technology sector like Analog Devices (ADI) and Texas Instruments (TXN).
  • These plans allow executives to sell shares in a pre-determined manner, avoiding accusations of insider trading.
  • The reported sales by Stephen Daly are consistent with typical insider trading activity under such plans.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholder sentiment, but it is unlikely to be significant given the pre-planned nature of the transactions.

Key Dates

DateDescription
05/31/2024Date the 10b5-1 trading plan was adopted by Stephen Daly.
11/13/2024Date of the stock sales by Stephen Daly.
11/15/2024Date the Form 4 was signed by Ambra R. Roth, Attorney-in-Fact.

Keywords

insider trading, stock sale, 10b5-1 plan, MACOM, Stephen Daly, executive, share transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.